Black Rose IndusQ2 FY25

Black Rose Indus Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹106.74P/E: 15.7Market Cap: ₹544 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • The company is focused on maximizing sales and profits in both distribution and manufacturing setups.
  • Stable sales are expected in the chemical distribution segment, supported by strong material availability and pricing from key principals.
  • Domestic volumes are projected to remain steady.
  • Merchant exports, especially to the US oil & gas sector, are anticipated to pick up, aiding volume growth.
  • Introduction of new products during the current and upcoming quarters is expected to expand the distribution portfolio.
  • Acrylamide Liquid market share is likely to grow locally as raw material prices stabilize.
  • Export volumes for manufacturing products are expected to increase with improving international logistics.
  • The new robust binder for Polyacrylamide Liquid is receiving good market traction, likely improving sales volumes.
  • N-methylol acrylamide sales are expected to be steady with consistent orders from key customers.
  • Future projects are supported by strategic land acquisition to enable quicker manufacturing capacity expansion.

See what Black Rose Indus management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • There is no mention of any current or planned fundraising through debt or equity in the transcript.
  • The company continues to maintain a zero long-term debt position, reflecting a very low debt-equity ratio.
  • No discussions or indications about raising capital via equity are presented.
  • Focus appears to be on internal growth, expanding manufacturing and distribution, acquiring land for future projects, and strengthening R&D.
  • Financial strategy highlights maintaining healthy return on equity and capital employed without resorting to debt financing.

See what Black Rose Indus management said on order book — free account, 30 seconds.

Capex plans

Yes
  • The company is setting up a new R&D facility, with work underway and expected completion by the end of the calendar year.
  • They are developing Polyacrylamide Solid technology, targeting an initial planned capacity of 10,000 MT per annum, expected to add substantially to revenue once commercialized.
  • Black Rose is actively acquiring about 20 acres of land to create a land bank for future manufacturing projects, aiming to reduce delays and enhance project viability.
  • They are progressing with an Environmental Clearance (EC) application for a new specialty chemicals project, hoping to secure clearances soon.
  • Strategic focus is on expanding manufacturing capacities for different products based on strong distribution relationships.
  • No specific announced capex amounts are mentioned, but these indicate ongoing and planned investments for growth and efficiency.

Track Black Rose Indus — get its next earnings analysis in your feed

How does Black Rose Indus rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisBlack Rose Indus
Rev 3Mar 3

How does Black Rose Indus rank in Chemicals & Petrochemicals?

Compare Black Rose Indus against every Chemicals & Petrochemicals company (Q2 FY25) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Seya Industries (Q2 FY27)

    Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's

  • DCM Shriram Fine Chemicals (Q2 FY27)

    9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri

  • Dhariwalcorp (Q2 FY27)

    For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…

  • Agastya Energy (Q2 FY27)

    For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →